Prospective, Open-labeled Trial in Patients With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea.
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2014
At a glance
- Drugs Bisoprolol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms PRISM
- Sponsors Merck KGaA
- 10 Jun 2017 Biomarkers information updated
- 30 Apr 2012 Planned end date changed from 1 Jun 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 23 Mar 2011 Planned end date changed from 1 May 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.